Human Investing’s AstraZeneca AZN Stock Holding History

Human Investing’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,206	Closed	-$120K	–	112
2021 Q1	$120K	Hold	1,206	–	–	0.03%	121
2020 Q4	$121K	Hold	1,206	–	–	0.03%	127
2020 Q3	$132K	Hold	1,206	–	–	0.04%	111
2020 Q2	$128K	Hold	1,206	–	–	0.05%	114
2020 Q1	$108K	Hold	1,206	–	–	0.05%	107
2019 Q4	$120K	Hold	1,206	–	–	0.04%	144
2019 Q3	$107K	Hold	1,206	–	–	0.04%	140
2019 Q2	$100K	Sell	1,206 -653	-35%	-$51.2K	0.04%	159
2019 Q1	$150K	Hold	1,859	–	–	0.06%	118
2018 Q4	$141K	Buy	+1,859	New	+$145K	0.06%	123

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Human Investing's AZN Position: Q2 2021 in Review

Human Investing sold out of AstraZeneca (AZN) in Q2 2021, closing a stake of 1,206 shares — an estimated $120K sold.

Human Investing first reported a position in AZN in Q4 2018 and held it in 10 quarters. The position peaked at $150K in Q1 2019. 771 funds tracked by Wall St. Rank hold AZN as of Q2 2021.

Human Investing reported no remaining AstraZeneca position as of Q2 2021 after selling out during the quarter.
Human Investing sold 1,206 AstraZeneca shares in Q2 2021, an estimated $120K.
Human Investing first reported a position in AstraZeneca in Q4 2018 and held it in 10 quarters.
Human Investing's AstraZeneca position peaked at $150K in Q1 2019.
771 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2021.

Based on Human Investing's 13F filing for Q2 2021, filed 2 Aug 2021.